For too long, hormone therapy has been inaccessible for cisgender men who need it - or so said clinicians, professors and a pharmaceutical CEO gathered this week by the Food and Drug Administration (FDA). Testosterone, a controlled substance, should be deregulated and patients should be able to access it at pharmacies without stigma, they said. Low testosterone in men is not just a cosmetic issue, they claimed - it's an American health crisis.
THE TOPLINE The FDA has stated it plans to remove all natural desiccated thyroid (NDT) products from the market within 12 months, impacting millions who rely on NDT for effective thyroid hormone replacement. Despite decades of safe use and minimal adverse event reports, the FDA demands costly approval processes that NDT manufacturers cannot realistically meet. This enforcement is part of a broader and long-term pattern of restricting access to natural and compounded medicines, limiting patient choice, and consolidating pharmaceutical industry control.
UC Irvine’s Sue and Bill Gross School of Nursing is one of two California schools planning to teach future mental health nurses how psychedelics can be used to treat mental health issues.